Comparing Approaches to Assess Nitric Oxide-dependent Cutaneous Vasodilation
University of Iowa · NCT06499844
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–30 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Early Phase 1
- Target enrollment
- 56
- US sites recruiting
- 1
- Study start
- August 1, 2024
- Record last updated
- August 24, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The increase in skin blood flow in response to rapid local heating of the skin (i.e., cutaneous vasodilation) is commonly used to assess nitric oxide (NO)-dependent dilation and overall microvascular function. Historically, rapid local heating to 42°C was considered the standard approach for these assessments. More recently, many investigators have adopted rapid local to 39°C instead, based on its larger dependency on NO and therefore improved ability to quantify NO-dependent dilation without the use of pharmacological techniques. However, to date, only one direct methodological comparison between these protocols has been performed.
In this study, the investigators use the blood vessels in the skin as a representative vascular bed for examining mechanisms of microvascular dysfunction in humans. Using a minimally invasive technique (intradermal microdialysis for the local delivery of pharmaceutical agents) they examine the blood vessels in a nickel-sized area of the skin in young adults ages 18 - 30 years old. Local heating of the skin at the microdialysis sites is used to explore differences in mechanisms governing microvascular control. As a compliment to these measurements, the investigators also have participants fill out a variety of surveys to assess things such as sleep quality, physical activity, daily stressors, etc.
Being studied: Acetylcholine
Conditions: Endothelial Function
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- men and women
- 18-30 years of age
Exclusion Criteria
- Current or recent (within 8 wks) use of medication that could conceivably alter microvascular function [including (but not limited to) stimulants, antihypertensives, HMG-CoA reductase inhibitors]
- Changes or alterations in medication status (starting a new, additional, or different medication or changing the dose of a current medication)
- Unstable or diagnosed chronic clinical disease, including cardiovascular, metabolic, renal, hepatic, autonomic, autoimmune, or dermatological disease (e.g., hypertension, heart disease, diabetes, hyperlipidemia, psoriasis)
- Body mass index \<18.5 or >35 kg/m2
- Pregnancy (including a positive urine pregnancy test) or breast-feeding
- Known allergies to pharmacological agents or study drugs
- Non-English-speaking. Participants need to understand English to follow instructions and comply with procedures conducted during the screening and experimental visits.
Recruiting US locations
University of Iowa
Iowa City, IA 52242
Site contact: Anna Stanhewicz, PhD · 319-467-1732 · anna-stanhewicz@uiowa.edu
Study contacts (from the official record)
- Anna Stanhewicz, PhD · 3194671732 · anna-stanhewicz@uiowa.edu
Similar studies in Iowa
All healthy volunteers studies in Iowa →- RecruitingHealthy volunteersPhase 1
A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
Novo Nordisk A/S
- Location
- Iowa City, IA + 4 other US sites
- Eligibility basics
- Ages 18–64 · Men only
- RecruitingHealthy volunteersPhase 1/Phase 2
Chronic Lung Allograft Dysfunction MRI Study
Sean Fain
- Location
- Iowa City, IA
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersEarly Phase 1
Oxidative Stress in Microvascular Dysfunction Following Gestational Diabetes
Anna Stanhewicz, PhD
- Location
- Iowa City, IA
- Eligibility basics
- Ages 18–50 · Women only
- RecruitingHealthy volunteersEarly Phase 1
Role of ET-1, Physical Activity, and Sedentary Behavior in Microvascular Dysfunction Following GDM
Anna Stanhewicz, PhD
- Location
- Iowa City, IA
- Eligibility basics
- Ages 18–50 · Women only